Valuation: Cryo-Cell International, Inc.

Market Cap 31.93M 27.58M 25.91M 23.57M 44.31M 3.05B 45.04M 304M 119M 1.53B 120M 117M 5.08B P/E 2026 *
49.5x
P/E 2027 * 396x
Enterprise Value 31.93M 27.58M 25.91M 23.57M 44.31M 3.05B 45.04M 304M 119M 1.53B 120M 117M 5.08B EV / Sales 2026 *
1.06x
EV / Sales 2027 * 1.12x
Free-Float
31.4%
Yield 2026 *
-
Yield 2027 * -
1 day+1.67%
1 week+10.00%
Current month+15.79%
1 month+16.47%
3 months+7.61%
6 months+15.55%
Current year+15.12%
1 week 3.13
Extreme 3.13
4.19
1 month 3.13
Extreme 3.13
4.19
Current year 2.72
Extreme 2.72
4.19
1 year 2.72
Extreme 2.72
5
3 years 2.72
Extreme 2.72
9.5
5 years 2.69
Extreme 2.69
14.16
10 years 0
Extreme 0
14.16
Manager TitleAgeSince
Chief Executive Officer 64 2011-07-31
Chief Executive Officer 63 2011-07-31
Director of Finance/CFO 57 1998-04-30
Director TitleAgeSince
Director/Board Member 63 2021-09-19
Chairman 64 2011-07-31
Director/Board Member 63 2011-08-24
Date Insider Type Main position Quantity % Market Cap.
8/5/26 OtherCompany 0 0%
8/5/26 Others

Chief Executive Officer

-1,200,382 14.8882%
1/7/26 Other

Chief Executive Officer

200,000 2.4829%
Change 5-day change 1-year change 3-year change Capi.($)
+1.67%+10.00%-3.65%-30.30% 31.4M
+2.28%+1.53%+45.60%+30.70% 121B
-1.71%-2.10%+2.80%+49.39% 89.14B
+0.56%+0.04%+2.19%+57.62% 31.14B
-0.69%-1.66%+31.36%+73.42% 26.05B
+0.32%+2.20%+55.43%+265.93% 21.5B
-1.64%-2.56%-10.08%-14.07% 21.29B
-2.55%-0.77%-9.20%+8.97% 14.5B
+0.12%-2.40%-3.55%-9.10% 12.53B
+0.50%-2.02%+33.98%+68.34% 11.43B
Average -0.45%+0.63%+14.49%+50.09% 34.91B
Weighted average by Cap. -0.98%+0.47%+22.52%+51.71%

Financials

2026 *2027 *
Net sales 30.04M 25.95M 24.38M 22.18M 41.69M 2.87B 42.38M 286M 112M 1.44B 113M 110M 4.78B 28.41M 24.54M 23.06M 20.97M 39.43M 2.72B 40.08M 270M 106M 1.36B 107M 104M 4.52B
Net income 634K 548K 515K 468K 880K 60.62M 894K 6.03M 2.36M 30.36M 2.38M 2.33M 101M 45K 38.87K 36.52K 33.22K 62.45K 4.3M 63.48K 428K 167K 2.15M 169K 165K 7.16M
Net Debt - -
Logo Cryo-Cell International, Inc.
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Employees
74
Date Price Change Volume
26-08-14 US$3.960 +1.67% 12,443
26-08-13 US$3.895 +0.39% 8,956
26-08-12 US$3.880 +10.54% 687,054
26-08-11 US$3.510 0.00% 10,022
26-08-10 US$3.510 -2.50% 6,265
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.960
Average target price
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CCEL Stock